Literature DB >> 292809

Effect of intestinal bacteria on incidence of liver tumors in gnotobiotic C3H/He male mice.

T Mizutani, T Mitsuoka.   

Abstract

The effect of intestinal microflora on liver tumorigenesis was studied in gnotobiotic C3H/He male mice monoassociated, diassociated, or polyassociated with the following strains of intestinal bacteria: Escherichia coli, Streptococcus faecalis, Bifidobacterium adolescentis, Bifidobacterium infantis, Clostridium indolis, C. paraputrificum, C. perfringens, C. innocuum, C. nexile, C. ramosum, C. clostridiiforme, Bacteroides multiacidus, Bacteroides fragilis, Veillonella alcalescens, V. parvula, and Lactobacillus acidophilus. The incidence of liver tumors was higher in most of the gnotobiotes (67--100%) and conventionalized mice (82%) derived from the germfree mice than in the germfree mice (39%). The average incidence of tumor nodules in gnotobiotes associated with E. coli, S. faecalis, and C. paraputrificum was 2.9, which was significantly higher than that in the conventionalized animals (1.6). In contrast, the average incidence of tumor nodules in gnotobiotes associated with E. coli, S. faecalis, L. acidophilus, C. perfringens, and Bacteroides fragilis (0.9) was not significantly different from that in germfree animals (0.5). The present study demonstrated that the presence of certain intestinal bacteria is related to liver tumorigenesis in gnotobiotic C3H/He male mice.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 292809

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  6 in total

Review 1.  Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either.

Authors:  Phillipp Hartmann; Huikuan Chu; Yi Duan; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-15       Impact factor: 4.052

2.  Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide.

Authors:  S Fujiwara; H Hashiba; T Hirota; J F Forstner
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

Review 3.  Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora.

Authors:  Hourieh Sadrekarimi; Zhanna R Gardanova; Morteza Bakhshesh; Farnoosh Ebrahimzadeh; Amirhossein Fakhre Yaseri; Lakshmi Thangavelu; Zahra Hasanpoor; Firoozeh Abolhasani Zadeh; Mohammad Saeed Kahrizi
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

4.  Effect of herbal medicine Juzentaihoto on hepatic and intestinal heat shock gene expression requires intestinal microflora in mouse.

Authors:  Miho Kato; Atsushi Ishige; Naoko Anjiki; Masahiro Yamamoto; Yoshifumi Irie; Mitsue Taniyama; Ryoko Kibe; Junichiro Oka; Yoshimi Benno; Kenji Watanabe
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

Review 5.  Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer.

Authors:  Se-Young Park; Byeong-Oh Hwang; Mihwa Lim; Seung-Ho Ok; Sun-Kyoung Lee; Kyung-Soo Chun; Kwang-Kyun Park; Yinling Hu; Won-Yoon Chung; Na-Young Song
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

Review 6.  Spontaneous and Induced Tumors in Germ-Free Animals: A General Review.

Authors:  Rajbardhan Mishra; Lenka Rajsiglová; Pavol Lukáč; Paolo Tenti; Peter Šima; Fabián Čaja; Luca Vannucci
Journal:  Medicina (Kaunas)       Date:  2021-03-11       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.